<DOC>
	<DOCNO>NCT02583698</DOCNO>
	<brief_summary>250 Acute chronic liver failure patient HVPG ( Hepatic Venous Pressure Gradient ) &gt; 12 mmHg + No/small esophageal varix present Department Hepatology Institute Liver Billiary Sciences , meet inclusion criterion provide inform consent .</brief_summary>
	<brief_title>Efficacy Nonselective Beta Blocker v Placebo Patients With Acute-on-chronic Liver Failure With Small/ Esophageal Varices</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>1 . Acute Chronic Liver Failure per APASL ( Asian Pacific Association Study Liver Disease ) criterion . 2 . 1875 year 3 . HVPG &gt; 12 + No/Small Esophageal varices 1 . Bradycardia ( HR &lt; 60/ min ) 2 . Hypotension 3 . Asthma 4 . LVF 5 . AKI ( Acute Kidney Injury ) 6 . Refractory ascites 7 . SBP ( Spontaneous Bacterial Peritonitis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>